Close Menu

Ready to Revise?

When preparing revisions to an NIH grant application, DrugMonkey says "one of the best starting places … is to think about the review process." For example, an investigator who plans to revise and resubmit should consider that his or her grant will "in most cases … go back to the same study section," DrugMonkey says, and, as such, it will likely be reviewed by someone who has already seen it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.